Start-up Of Former Pfizer Employees Receives $4 Million

Photo courtesy of St. Louis Post-Dispatch / Confluence Discovery Technologies Chief Executive Officer Walter Smith (left) and President Joseph Monahan have landed $4 million of financing after their research scientists in shared labs in the Cortex Building developed a breakthrough drug process that inhibits growth of pancreatic cancer cells.

Barely two years after getting laid off with hundreds of other researchers at Pfizer’s drug research campus in Chesterfield, Joseph Monahan is poised to embark on the most significant research of his career.

Credit for the turnabout goes to the advances made in the development of cutting edge therapeutics at a post-Pfizer startup co-founded by Monahan — research that has now gained $4 million in venture capital funding.

In a short time, the Confluence Life Sciences has helped validate the belief, met with skepticism in some quarters, that St. Louis can compete with Boston, San Francisco and the North Carolina Research Triangle and other regions dominating global bioscience  research and production.

Read more on St. Louis Post-Dispatch.


Tags:, ,

Leave a Reply

Have you heard?

Missouri Business Alert is participating in CoMoGives2019!

Find out how we plan to use your gift to enhance training and programming for our students